Hepatic gene expression and lipid homeostatis in C57Bl/6 mice exposed to hydrazine or acetylhydrazine

Toxicological Sciences

Volumn 82, Issue 1, 2004, Pages 318-332

  Richards, Victoria E ^a   Chau, Binh ^a   White, M Randy ^b   McQueen, Charlene A ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b PRI   (United States)

Author keywords

Acetylhydrazine; cDNA microarray; Hepatoxicity; Hydrazine; Peroxisome proliferator activated receptor; Steatosis

Indexed keywords

ACETOHYDRAZIDE; ALANINE AMINOTRANSFERASE; HYDRAZINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; STEROL REGULATORY ELEMENT BINDING PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CELL DEATH; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE SEQUENCE; HISTOPATHOLOGY; HOMEOSTASIS; LIPID METABOLISM; LIPID STORAGE; LIPID TRANSPORT; LIPOGENESIS; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; UNINDEXED SEQUENCE;

ADMINISTRATION, ORAL; ANIMALS; CARCINOGENS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEPATITIS, TOXIC; HOMEOSTASIS; HYDRAZINES; LIPID METABOLISM; LIPIDS; LIVER; MALE; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGANIZATION AND ADMINISTRATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 8444230842     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/kfh232     Document Type: Article

References (42)

1. Akiyama, T. E., Sakai, S., Lambert, G., Nicol, C. J., Matsusue, K., Pimprale, S., Lee, Y.-H., Ricote, M., Glass, C. K., Brewer, H. B., Jr., et al. (2002). Conditional disruption of the peroxisome proliferator-activated receptor γ gene in mice results in lowered expression of Abca1, Abcg1, and apoE in macrophages and reduced cholesterol efflux. Mol. Cell. Biol. 22(8), 2607-2619.
2. Amenta, J. S., and Dominguez, A. M. (1965). Fatty acid flux and triglyceride secretion in the hydrazine-induced fatty liver. Exp. Mol. Pathol. 4, 282-302.
3. Bahri, A. K., Chiang, C. S., and Timbrell, J. A. (1981). Factors affecting acetylhydrazine hepatotoxicity. Adv. Exp. Med. Biol. 136, 1015-1065.
4. Choudhary, G., and Hansen, H. (1998). Human health perspective on environmental exposure to hydrazine: A review. Chemosphere 37, 801-843.
5. Clark, D. A., Leeder, L. G., Foulds, E. L., and Trout, D. L. (1970). Changes in lipids of rat liver after hydrazine injection. Biochem. Pharmacol. 19, 1743-1752.
6. Clarke, S. D., Thuillier, P., Baillie, R. A., and Sha, X. (1999). Peroxisome proliferator-activated receptors: A family of lipid activated transcription factors. Amer. J. Clin. Nutr. 70, 566-571.
7. Danen, E. H. J., and Yamada, K. M. (2001). Fibronectin, integrins and growth control. J. Cell. Physiol. 189, 1-13.
8. Forman, B. M., Chen, J., and Evans, R. M. (1997). Hypolipidemic drugs, poly-unsaturated fatty acids, and eicosanoids are ligands for peroxisome proilferator-activated receptors α and δ. Proc. Natl. Acad. Sci. U.S.A. 94, 4312-4317.
9. Gavrilova, O., Haluzik, M., Matsusue, K, Cutson, J. J., Johnson, L., Dietz, K. R., Nicol, C. J., Vinson, C., Gonzalez, F. J., and Retiman, M. L. (2003). Liver peroxisome proliferator-activated receptor γ contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J. Biol. Chem. 278(36), 34268-34276.
10. Horton, J. D. (2002). Sterol regulatory element-binding proteins: Transcriptional activators of lipid synthesis. Biochem. Soc. Trans. 30, 1091-1095.
11. Hulthe, J., Hulten, L. M., and Fagerberg, B. (2003). Low adipocyte-derived plasma protein adiponectin concentrations are associated with the metabolic syndrome and small dense low-density lipoprotein particles: Atherosclerosis and insulin resistance study. Metabolism 52, 1612-1614.
12. Hussain, S. M., and Frazier J. M. (2002). Cellular toxicity of hydrazine in primary rat hepatocytes. Toxicol. Sci. 69, 424-432.
13. Jenner, A. M., and Timbrell, J. A. (1995). In vitro microsomal metabolism of hydrazine. Xenobiotica. 25, 599-609.
14. Kasus-Jacobi, A., Ou, J., Bashmakov, Y. K., Shelton, J. M., Richardson, J. A., Goldstein, J. L., and Brown, M. S. (2003). Characterization of mouse short-chain aldehyde reductase (SCALD), and enzyme regulated by sterol regulatory element-binding proteins. J. Biol. Chem. 278, 32380-32389.
15. Kobayashi, T., Niimi, S., Kawanishi, T., Fukuoka, M., and Hayakawa, T. (2003). Changes in peroxisome proliferator-activated receptor gamma-regulated gene expression and inhibin/activin-follistatin system gene expression in rat testis after an administration of di-n-butyl phthalate. Toxicol. Lett. 138, 215-225.
16. Lamb, R. G., and Banks, W. L. (1979). Effect of HD exposure on hepatic triacylglycerol biosynthesis. Biochim. Biophys. Acta. 574, 440-447.
17. Lauterburg, B. H., Smith, C. V., Todd, E. L., and Mitchell, J. R. (1985). Pharmacokinetics of the toxic HD metabolites formed from isoniazid in humans. J. Pharmacol. Exp. Ther. 235, 566-570.
18. Lee, C.-H., Olson, P., and Evans, R. M. (2003). Minireview: Lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology 144(6), 2201-2207.
19. Le May, C., Pineay, T., Bigot, K., Kohl, C., Girard, J., and Pérgorier, J.-P. (2000). Reduced hepatic fatty acid oxidation in fasting PPARα null mice is due to impaired mitochondrial hydroxymethylglutaryl-CoA synthase gene expression. FEBS Lett. 475, 163-166.
20. Madsen, L., Garras, A., Asins, G., Serra, D., Hegardt, F. G., and Berge, R. K. (1999). Mictochondrial 3-hydroxy-3-methylglutaryl coenzyme A synthase and carnitine palmitoyltransferase II as potential control sites for ketogenesis during mitochondrion and peroxisome proliferation. Biochem. Pharmacol. 57, 1011-1019.
21. Maxwell, K. N., Soccio, R. E., Duncan, E. M., Sehayek, E., and Breslow, J. L. (2003). Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-fed mice. J. Lipid. Res. 44, 2109-2119.
22. McQueen, C. A., and Chau, B. (2003). Neonatal ontogeny of murine arylamine N-acetyltransferases: Implications for arylamine genotoxicity. Toxicol. Sci. 73, 279-286.
23. Mitchell, J. R., Thorgeirsson, U. P., Black, M., Timbrell, J. A., Snodgrass, W. R., Potter, W. Z., Jollow, H. R., and Keiser, H. R. (1975). Increased incidence of isoniazid hepatitis in rapid acetylators: Possible relation to hydrazine metabolites. Clin. Pharmacol. Ther. 18, 70-79.
24. Patel, L., Buckels, A. C., Kinghorn, I. J., Murdock, P. R., Holbrook, J. D., Plumpton, C., Macphee, C. H., and Smith, S. A. (2003). Resistin is expressed in human macrophages and directly regulated by PPARg activators. Biochem. Biophys. Res. Commun. 300, 472-476.
25. 15N-NMR. Biochem. Pharmacol. 41, 1319-1324.
26. Rao, M. S., and Reddy, J. K. (2001). Peroxisomal beta-oxidation and steato-hepatitis. Semin. Liver Dis. 21, 43-55.
27. Rawson, R. (2003) The SREBP pathway - insights fron insigs and insects. Nature Rev. Mol. Cell Biol. 4, 631-640.
28. Reddy, J. K. (2001) Nonalcoholic steatosis and steatohepatitis III: Peroxisomal β-oxidation, PPARα, and steatohepatitis. Am. J. Physiol. Gastrointest. Liver Physiol. G1333-G1339.
29. Runge-Morris, M., Feng, Y., Zangar, R. C., and Novak, R. F. (1996) Effects of hydrazine, phenylezine, and hydralazine treatment on rat hepatic and renal drug-metabolizing enzyme expression. Drug Metab. Dispo. 24, 734-737.
30. Sarich, T. C., Adams, S. P., Petricca, G., and Wright, J. M. (1999). Inhibition of isoniazid-induced hepatotoxicity in rabbits by pretreatment with an amidase inhibitor. J. Pharmacol. Exp. Ther. 289, 695-702.
31. Sasaki, Y. F., Saga, A., Akasaka, M., Ishibashi, S., Yoshida, K., Su, Y. Q., Matsusaka, N., and Tsuda, S. (1998). Organ-specific genotoxicity of the potent rodent colon carcinogen 1,2-dimethylhydrazine and three hydrazine derivatives: Difference between intraperitoneal and oral administration. Mutat. Res. 415, 1-12.
32. Scales, M. D., and Timbrell, J. A. (1982). Studies on hydrazine hepatotoxicity. 1. Pathological findings. J. Toxicol. Environ. Health 10, 941-953.
33. Stan, S., Delvin, E., Lambert, M., and Seidman, E. (2003) Apo A-IV: An update on regulation and physiologic functions. Biochim. Biophys. Acta 1631, 177-187.
34. Stuart, R. L., and Grayson, M. L. (1999). A review of isoniazid-related hepatotoxicity during chemoprophylaxis. Aust. N.Z. J. Med. 29, 362-367.
35. Timbrell, J. A., Mitchell, J. R., Snodgrass, W. R., and Nelson, S. D. (1980). Isoniazid hepatotoxicity: The relationship between covalent binding and metabolism in vivo. J. Pharmacol. Exp. Ther. 213, 364-369.
36. Timbrell, J. A., Scales, M. D., and Streeter, A. J. (1982). Studies on hydrazine hepatotoxicity. 2. Biochemical findings. J. Toxicol. Environ. Health. 10, 955-968.
37. Timbrell, J. A., and Wright, J. M. (1984). Urinary metabolic profile of isoniazid in patients developing isoniazid related liver damage. Hum. Toxicol. 3, 485-495.
38. Trout, D. L. (1965). Effect of hydrazine on plasma free fatty acid transport. Biochem. Pharmacol. 14, 813-821.
39. van der Vliet, H. N., Sammel, M. G., Leegwater, A. C. J, Levels, J. H. M, Reitsma, P. H., Boers, W., and Chamuleau, A. F. M. (2001). Apolipoprotein A-V: A novel apolipoprotein associated with an early phase of liver regeneration. J. Biol. Chem. 276, 44512-44520.
40. Vu-Dac, N., Gervois, P., Jakel, H., Nowak, N., Baugé, E., Dehondt, H., Staels, B., Pennacchio, L. A., Rubin, E. M., Fruchart-Najib, J., et al. (2003). Apolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to PPARα activators. J. Biol. Chem. 278, 17982-17985.
41. Walubo, A., Smith, P., and Folb, P. I. (1998). The role of oxygen free radicals in isoniazid-induced hepatotoxicity. Methods Find. Exp. Clin. Pharmacol. 20, 649-655.
42. Weber, W. W. (1987). The Acetylator Genes and Drug Response, pp. 1-248. Oxford Press, New York.